Report title: Novartis AG acquires Zhejiang Tianyuan Bio-pharm Co (pending)
from Thomson Financial Mergers & Acquisitions
published Nov 04, 2009

Price $48.00 available for immediate download
Report Overview
 
About Thomson Financial Mergers & Ac...

CHINA - Novartis AG of Switzerland planned to acquire ##% interest in Zhejiang Tianyuan Bio- Pharmaceutical Co, a Zhejiang- based manufacturer of vaccines, for an estimated CNY ### mil (USD ###.### mil).

Acquirer: Novartis AG
Acquirer Business Discription: Mnfr pharm
Acquirer SIC Code: 2834 - Pharmaceutical preparations
Target Name: Zhejiang Tianyuan Bio-pharm Co
Target Business Description: Mnfr,whl vaccines
Target SIC Code: 2834 - Pharmaceutical preparations
Please Note: Target Financials are not included in this report.Explain

Free Sample: Click Here to Download
Format:
PDF Adobe Acrobat


Price: $48.00



  Can't Decide?

Purchasing premium research sight unseen can be intimidating. At Alacra we want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.